3rd, W. R., PJ, O., SA, R., TD, N., & AS, D. (2024). Development and validation of an ultra-high performance liquid chromatography-tandem mass spectrometry method to quantify antiretroviral drug concentrations in human plasma for therapeutic monitoring. Journal of pharmaceutical and biomedical analysis, 240, 115932. https://doi.org/10.1016/j.jpba.2023.115932
Chicago Style (17th ed.) Citation3rd, West RE, Oberly PJ, Riddler SA, Nolin TD, and Devanathan AS. "Development and Validation of an Ultra-high Performance Liquid Chromatography-tandem Mass Spectrometry Method to Quantify Antiretroviral Drug Concentrations in Human Plasma for Therapeutic Monitoring." Journal of Pharmaceutical and Biomedical Analysis 240 (2024): 115932. https://doi.org/10.1016/j.jpba.2023.115932.
MLA (9th ed.) Citation3rd, West RE, et al. "Development and Validation of an Ultra-high Performance Liquid Chromatography-tandem Mass Spectrometry Method to Quantify Antiretroviral Drug Concentrations in Human Plasma for Therapeutic Monitoring." Journal of Pharmaceutical and Biomedical Analysis, vol. 240, 2024, p. 115932, https://doi.org/10.1016/j.jpba.2023.115932.